Article
Exclusive: Pfizer plans to start human studies of its Omicron-specific COVID-19 vaccine before the end of January
Rating:
0.0
Views:
69
Likes:
1
Library:
1
The pharma giant is on track to have a new version of its vaccine ready by late March, its chief scientist, Mikael Dolsten, told Insider.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value